United States Pharmaceuticals

Collegium Pharmaceutical Inc (COLL)

Track

Track

Collegium Pharmaceutical Inc. experienced significant insider trading activity recently, characterized exclusively by divestments. Directors and executives offloaded shares totaling approximately $791,440 over the past quarter. These sales occurred amid a 16.8% decline in stock value, following a positive earnings report where the firm exceeded profit expectations by 6.08%.
Ticker: COLL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Collegium Pharmaceutical Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Fallon John A. Former Director Non-Executive Director
Transaction date
Proposed sale
Price
374.12
Quantity 5,642
Value US$3,547,799
2.2
Fallon John A. Former Director Non-Executive Director
Transaction date
Proposed sale
Price
438.29
Quantity 89,746
Value US$511,564
2.2
Freund John Gordon Non-Executive Director
Transaction date
Sale
Price
178.52
Quantity 73,430 -27.9%
Value US$1,303,739
2.2
Freund John Gordon Director Non-Executive Director
Transaction date
Proposed sale
Price
34.05
Quantity 30
Value US$1,022
2.2
Freund John Gordon Non-Executive Director
Transaction date
Sale
Price
34.54
Quantity 4,127 -4.7%
Value US$142,547
2.2
Freund John Gordon Non-Executive Director
Transaction date
Sale
Price
34.54
Quantity 4,127 -4.7%
Value US$142,547
2.2
Freund John Gordon Director Non-Executive Director
Transaction date
Proposed sale
Price
34.54
Quantity 4,127
Value US$142,547
3.4
Lurker Nancy Non-Executive Director
Transaction date
Sale
Price
35.97
Quantity 4,500 -20.0%
Value US$161,861
3.4
Lurker Nancy Director Non-Executive Director
Transaction date
Proposed sale
Price
35.97
Quantity 4,500
Value US$161,861
2.4
BOHLIN GAREN G Non-Executive Director
Transaction date
Sale
Price
37.18
Quantity 8,700 -12.3%
Value US$323,491
2.4
BOHLIN GAREN G Director Non-Executive Director
Transaction date
Proposed sale
Price
37.18
Quantity 8,700
Value US$323,491
Dieter David EVP & General Counsel Officer
Transaction date
Planned sale
Price
34.92
Quantity 13,976 -15.4%
Value US$488,099
Dieter David Officer Officer
Transaction date
Proposed sale
Price
34.92
Quantity 13,976
Value US$488,099
Dieter David EVP & General Counsel Officer
Transaction date
Planned sale
Price
36.65
Quantity 6,224 -6.4%
Value US$228,110
Dieter David Officer Officer
Transaction date
Proposed sale
Price
36.65
Quantity 6,224
Value US$228,110
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
40.99
Quantity 3,559 -4.7%
Value US$145,879
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
40.36
Quantity 46,417 -38.1%
Value US$1,873,557
1.9
Dreyer Scott Officer Officer
Transaction date
Proposed sale
Price
40.41
Quantity 49,976
Value US$2,019,439
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
48.66
Quantity 6,475 -5.9%
Value US$315,085
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
47.89
Quantity 11,125 -9.2%
Value US$532,771
1.9
Dreyer Scott Officer Officer
Transaction date
Proposed sale
Price
48.17
Quantity 17,600
Value US$847,855
3.1
RITA BALICE-GORDON DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
47.03
Quantity 3,650
Value US$171,673
3.1
Balice-Gordon Rita J. Non-Executive Director
Transaction date
Sale
Price
47.03
Quantity 3,650 -6.5%
Value US$171,673
2.2
Fallon John A. Non-Executive Director
Transaction date
Sale
Price
47.21
Quantity 34,853 -35.0%
Value US$1,645,536
2.2
Fallon John A. Director Non-Executive Director
Transaction date
Proposed sale
Price
47.21
Quantity 34,853
Value US$1,645,536
Tupper Colleen EVP & Chief Financial Officer Officer
Transaction date
Planned sale
Price
41.28
Quantity 4,858 -3.7%
Value US$200,517
Tupper Colleen EVP & Chief Financial Officer Officer
Transaction date
Planned sale
Price
40.38
Quantity 25,142 -16.0%
Value US$1,015,236
Tupper Colleen Officer Officer
Transaction date
Proposed sale
Price
40.53
Quantity 30,000
Value US$1,215,754
2.4
Smith Thomas B EVP and Chief Medical Officer Officer
Transaction date
Sale
Price
38.42
Quantity 17,478 -19.9%
Value US$671,576
2.4
Smith Thomas B Officer Officer
Transaction date
Proposed sale
Price
38.42
Quantity 17,478
Value US$671,576
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
38.21
Quantity 16,389 -13.7%
Value US$626,171
1.9
Dreyer Scott Officer Officer
Transaction date
Proposed sale
Price
38.21
Quantity 16,389
Value US$626,170
2.1
SANTINI GINO Non-Executive Director
Transaction date
Sale
Price
37.19
Quantity 5,405 -5.4%
Value US$201,018
2.1
SANTINI GINO Director Non-Executive Director
Transaction date
Proposed sale
Price
37.19
Quantity 5,405
Value US$201,019
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
38.03
Quantity 4,861 -4.5%
Value US$184,881
1.9
Dreyer Scott Officer Officer
Transaction date
Proposed sale
Price
38.03
Quantity 4,861
Value US$184,881
2.2
Freund John Gordon Non-Executive Director
Transaction date
Sale
Price
34.36
Quantity 11,659 -33.5%
Value US$400,641
Heffernan Michael Thomas Former Director Non-Executive Director
Transaction date
Proposed sale
Price
32.17
Quantity 10,328
Value US$332,269
Heffernan Michael Thomas Former Director Non-Executive Director
Transaction date
Proposed sale
Price
31.38
Quantity 790
Value US$24,792
Heffernan Michael Thomas Former Director Non-Executive Director
Transaction date
Proposed sale
Price
31.25
Quantity 14,210
Value US$444,062
Heffernan Michael Thomas Former Director Non-Executive Director
Transaction date
Proposed sale
Price
30.30
Quantity 25,000
Value US$757,380
3.1
Melincoff Gwen A Former Director Non-Executive Director
Transaction date
Proposed sale
Price
30.29
Quantity 47,082
Value US$1,425,971
2.2
Freund John Gordon Non-Executive Director
Transaction date
Sale
Price
30.62
Quantity 6,601 -8.5%
Value US$202,149
2.2
Freund John Gordon Director Non-Executive Director
Transaction date
Proposed sale
Price
30.62
Quantity 6,601
Value US$202,148
Tupper Colleen EVP & Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.03
Quantity 6,396 -3.9%
Value US$192,069
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
30.03
Quantity 18,881 -15.4%
Value US$566,983
Tupper Colleen Officer Officer
Transaction date
Proposed sale
Price
30.03
Quantity 6,396
Value US$192,069
1.9
Dreyer Scott Officer Officer
Transaction date
Proposed sale
Price
30.03
Quantity 18,881
Value US$566,984
Tupper Colleen EVP & Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 1,206 -0.7%
Value US$36,181
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 1,927 -1.5%
Value US$57,811
Tupper Colleen Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 1,206
Value US$36,181
2.2
Kuhlmann Shirley R. Former Officer Officer
Transaction date
Proposed sale
Price
29.65
Quantity 40,494
Value US$1,200,632
1.9
Dreyer Scott Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 1,927
Value US$57,811
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 2,255 -1.8%
Value US$67,661
Tupper Colleen EVP & Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 977 -0.6%
Value US$29,313
Tupper Colleen Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 977
Value US$29,313
1.9
Dreyer Scott Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 2,255
Value US$67,661
Tupper Colleen EVP & Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.01
Quantity 10,445 -5.9%
Value US$313,413
Tupper Colleen Officer Officer
Transaction date
Proposed sale
Price
30.01
Quantity 10,445
Value US$313,413
1.9
Dreyer Scott Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 15,387
Value US$461,672
Tupper Colleen EVP & Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 1,504 -0.8%
Value US$45,121
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 2,348 -1.6%
Value US$70,446
1.9
Dreyer Scott Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 2,348
Value US$70,446
Tupper Colleen Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 1,504
Value US$45,121
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 15,387 -10.8%
Value US$461,672
Tupper Colleen EVP & Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 1,949 -1.1%
Value US$58,470
1.9
Dreyer Scott EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 3,295 -2.2%
Value US$98,854
Tupper Colleen Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 1,949
Value US$58,470
1.9
Dreyer Scott Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 3,295
Value US$98,854
2.2
Kuhlmann Shirley R. Officer Officer
Transaction date
Proposed sale
Price
28.50
Quantity 26,067
Value US$742,946
2.2
Kuhlmann Shirley R. EVP and General Counsel Officer
Transaction date
Sale
Price
28.50
Quantity 26,067 -19.4%
Value US$742,946
2.2
Kuhlmann Shirley R. EVP and General Counsel Officer
Transaction date
Sale
Price
28.03
Quantity 20,000 -13.0%
Value US$560,528
2.2
Kuhlmann Shirley R. Officer Officer
Transaction date
Proposed sale
Price
28.03
Quantity 20,000
Value US$560,528
2.2
Kuhlmann Shirley R. EVP and General Counsel Officer
Transaction date
Sale
Price
28.08
Quantity 40,000 -20.6%
Value US$1,123,160
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-17 2026-07-17 PrS Proposed sale
2.2
Fallon John A.

Former Director

Non-Executive Director
5,642
374.12
US$3,547,799 		5,642 374.12 US$3,547,799
2026-07-15 2026-07-15 PrS Proposed sale
2.2
Fallon John A.

Former Director

Non-Executive Director
89,746
438.29
US$511,564 		89,746 438.29 US$511,564
2026-05-20 2026-05-18 S Sale
2.2
Freund John Gordon
Non-Executive Director
73,430 -27.9%
178.52
US$1,303,739 		73,430 -27.9% 178.52 US$1,303,739
2026-05-18 2026-05-18 PrS Proposed sale
2.2
Freund John Gordon

Director

Non-Executive Director
30
34.05
US$1,022 		30 34.05 US$1,022
2026-05-18 2026-05-15 S Sale
2.2
Freund John Gordon
Non-Executive Director
4,127 -4.7%
34.54
US$142,547 		4,127 -4.7% 34.54 US$142,547
2026-05-18 2026-05-15 S Sale
2.2
Freund John Gordon
Non-Executive Director
4,127 -4.7%
34.54
US$142,547 		4,127 -4.7% 34.54 US$142,547
2026-05-15 2026-05-15 PrS Proposed sale
2.2
Freund John Gordon

Director

Non-Executive Director
4,127
34.54
US$142,547 		4,127 34.54 US$142,547
2026-05-15 2026-05-13 S Sale
3.4
Lurker Nancy
Non-Executive Director
4,500 -20.0%
35.97
US$161,861 		4,500 -20.0% 35.97 US$161,861
2026-05-13 2026-05-13 PrS Proposed sale
3.4
Lurker Nancy

Director

Non-Executive Director
4,500
35.97
US$161,861 		4,500 35.97 US$161,861
2026-05-13 2026-05-11 S Sale
2.4
BOHLIN GAREN G
Non-Executive Director
8,700 -12.3%
37.18
US$323,491 		8,700 -12.3% 37.18 US$323,491
2026-05-11 2026-05-11 PrS Proposed sale
2.4
BOHLIN GAREN G

Director

Non-Executive Director
8,700
37.18
US$323,491 		8,700 37.18 US$323,491
2026-03-20 2026-03-18 PlS Planned sale
Dieter David

EVP & General Counsel

Officer
13,976 -15.4%
34.92
US$488,099 		13,976 -15.4% 34.92 US$488,099
2026-03-18 2026-03-18 PrS Proposed sale
Dieter David

Officer

Officer
13,976
34.92
US$488,099 		13,976 34.92 US$488,099
2026-03-11 2026-03-09 PlS Planned sale
Dieter David

EVP & General Counsel

Officer
6,224 -6.4%
36.65
US$228,110 		6,224 -6.4% 36.65 US$228,110
2026-03-09 2026-03-09 PrS Proposed sale
Dieter David

Officer

Officer
6,224
36.65
US$228,110 		6,224 36.65 US$228,110
2026-03-05 2026-03-03 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
3,559 -4.7%
40.99
US$145,879 		3,559 -4.7% 40.99 US$145,879
2026-03-05 2026-03-03 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
46,417 -38.1%
40.36
US$1,873,557 		46,417 -38.1% 40.36 US$1,873,557
2026-03-03 2026-03-03 PrS Proposed sale
1.9
Dreyer Scott

Officer

Officer
49,976
40.41
US$2,019,439 		49,976 40.41 US$2,019,439
2025-12-10 2025-12-08 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
6,475 -5.9%
48.66
US$315,085 		6,475 -5.9% 48.66 US$315,085
2025-12-10 2025-12-08 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
11,125 -9.2%
47.89
US$532,771 		11,125 -9.2% 47.89 US$532,771
2025-12-08 2025-12-08 PrS Proposed sale
1.9
Dreyer Scott

Officer

Officer
17,600
48.17
US$847,855 		17,600 48.17 US$847,855
2025-12-17 2025-12-05 PrS Proposed sale
3.1
RITA BALICE-GORDON

DIRECTOR

Non-Executive Director
3,650
47.03
US$171,673 		3,650 47.03 US$171,673
2025-12-09 2025-12-05 S Sale
3.1
Balice-Gordon Rita J.
Non-Executive Director
3,650 -6.5%
47.03
US$171,673 		3,650 -6.5% 47.03 US$171,673
2025-11-14 2025-11-12 S Sale
2.2
Fallon John A.
Non-Executive Director
34,853 -35.0%
47.21
US$1,645,536 		34,853 -35.0% 47.21 US$1,645,536
2025-11-12 2025-11-12 PrS Proposed sale
2.2
Fallon John A.

Director

Non-Executive Director
34,853
47.21
US$1,645,536 		34,853 47.21 US$1,645,536
2025-11-07 2025-11-06 PlS Planned sale
Tupper Colleen

EVP & Chief Financial Officer

Officer
4,858 -3.7%
41.28
US$200,517 		4,858 -3.7% 41.28 US$200,517
2025-11-07 2025-11-06 PlS Planned sale
Tupper Colleen

EVP & Chief Financial Officer

Officer
25,142 -16.0%
40.38
US$1,015,236 		25,142 -16.0% 40.38 US$1,015,236
2025-11-06 2025-11-06 PrS Proposed sale
Tupper Colleen

Officer

Officer
30,000
40.53
US$1,215,754 		30,000 40.53 US$1,215,754
2025-09-03 2025-08-29 S Sale
2.4
Smith Thomas B

EVP and Chief Medical Officer

Officer
17,478 -19.9%
38.42
US$671,576 		17,478 -19.9% 38.42 US$671,576
2025-08-29 2025-08-29 PrS Proposed sale
2.4
Smith Thomas B

Officer

Officer
17,478
38.42
US$671,576 		17,478 38.42 US$671,576
2025-08-20 2025-08-18 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
16,389 -13.7%
38.21
US$626,171 		16,389 -13.7% 38.21 US$626,171
2025-08-18 2025-08-18 PrS Proposed sale
1.9
Dreyer Scott

Officer

Officer
16,389
38.21
US$626,170 		16,389 38.21 US$626,170
2025-08-19 2025-08-15 S Sale
2.1
SANTINI GINO
Non-Executive Director
5,405 -5.4%
37.19
US$201,018 		5,405 -5.4% 37.19 US$201,018
2025-08-15 2025-08-15 PrS Proposed sale
2.1
SANTINI GINO

Director

Non-Executive Director
5,405
37.19
US$201,019 		5,405 37.19 US$201,019
2025-08-15 2025-08-13 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
4,861 -4.5%
38.03
US$184,881 		4,861 -4.5% 38.03 US$184,881
2025-08-15 2025-08-13 S Sale
3.6
Rubric Capital Management LP
Large shareholder
25,000 -0.8%
37.85
US$946,250 		25,000 -0.8% 37.85 US$946,250
2025-08-13 2025-08-13 PrS Proposed sale
1.9
Dreyer Scott

Officer

Officer
4,861
38.03
US$184,881 		4,861 38.03 US$184,881
2025-08-12 2025-08-08 S Sale
2.2
Freund John Gordon
Non-Executive Director
11,659 -33.5%
34.36
US$400,641 		11,659 -33.5% 34.36 US$400,641
2025-07-09 2025-07-09 PrS Proposed sale
Heffernan Michael Thomas

Former Director

Non-Executive Director
10,328
32.17
US$332,269 		10,328 32.17 US$332,269
2025-07-08 2025-07-08 PrS Proposed sale
Heffernan Michael Thomas

Former Director

Non-Executive Director
790
31.38
US$24,792 		790 31.38 US$24,792
2025-07-07 2025-07-07 PrS Proposed sale
Heffernan Michael Thomas

Former Director

Non-Executive Director
14,210
31.25
US$444,062 		14,210 31.25 US$444,062
2025-07-02 2025-07-02 PrS Proposed sale
Heffernan Michael Thomas

Former Director

Non-Executive Director
25,000
30.30
US$757,380 		25,000 30.30 US$757,380
2025-07-02 2025-07-02 PrS Proposed sale
3.1
Melincoff Gwen A

Former Director

Non-Executive Director
47,082
30.29
US$1,425,971 		47,082 30.29 US$1,425,971
2025-06-11 2025-06-09 S Sale
2.2
Freund John Gordon
Non-Executive Director
6,601 -8.5%
30.62
US$202,149 		6,601 -8.5% 30.62 US$202,149
2025-06-09 2025-06-09 PrS Proposed sale
2.2
Freund John Gordon

Director

Non-Executive Director
6,601
30.62
US$202,148 		6,601 30.62 US$202,148
2025-03-24 2025-03-21 PlS Planned sale
Tupper Colleen

EVP & Chief Financial Officer

Officer
6,396 -3.9%
30.03
US$192,069 		6,396 -3.9% 30.03 US$192,069
2025-03-24 2025-03-21 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
18,881 -15.4%
30.03
US$566,983 		18,881 -15.4% 30.03 US$566,983
2025-03-21 2025-03-21 PrS Proposed sale
Tupper Colleen

Officer

Officer
6,396
30.03
US$192,069 		6,396 30.03 US$192,069
2025-03-21 2025-03-21 PrS Proposed sale
1.9
Dreyer Scott

Officer

Officer
18,881
30.03
US$566,984 		18,881 30.03 US$566,984
2025-03-24 2025-03-20 PlS Planned sale
Tupper Colleen

EVP & Chief Financial Officer

Officer
1,206 -0.7%
30.00
US$36,181 		1,206 -0.7% 30.00 US$36,181
2025-03-24 2025-03-20 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
1,927 -1.5%
30.00
US$57,811 		1,927 -1.5% 30.00 US$57,811
2025-03-20 2025-03-20 PrS Proposed sale
Tupper Colleen

Officer

Officer
1,206
30.00
US$36,181 		1,206 30.00 US$36,181
2025-03-20 2025-03-20 PrS Proposed sale
2.2
Kuhlmann Shirley R.

Former Officer

Officer
40,494
29.65
US$1,200,632 		40,494 29.65 US$1,200,632
2025-03-20 2025-03-20 PrS Proposed sale
1.9
Dreyer Scott

Officer

Officer
1,927
30.00
US$57,811 		1,927 30.00 US$57,811
2025-03-18 2025-03-14 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
2,255 -1.8%
30.00
US$67,661 		2,255 -1.8% 30.00 US$67,661
2025-03-18 2025-03-14 PlS Planned sale
Tupper Colleen

EVP & Chief Financial Officer

Officer
977 -0.6%
30.00
US$29,313 		977 -0.6% 30.00 US$29,313
2025-03-14 2025-03-14 PrS Proposed sale
Tupper Colleen

Officer

Officer
977
30.00
US$29,313 		977 30.00 US$29,313
2025-03-14 2025-03-14 PrS Proposed sale
1.9
Dreyer Scott

Officer

Officer
2,255
30.00
US$67,661 		2,255 30.00 US$67,661
2025-03-13 2025-03-11 PlS Planned sale
Tupper Colleen

EVP & Chief Financial Officer

Officer
10,445 -5.9%
30.01
US$313,413 		10,445 -5.9% 30.01 US$313,413
2025-03-11 2025-03-11 PrS Proposed sale
Tupper Colleen

Officer

Officer
10,445
30.01
US$313,413 		10,445 30.01 US$313,413
2025-03-11 2025-03-11 PrS Proposed sale
1.9
Dreyer Scott

Officer

Officer
15,387
30.00
US$461,672 		15,387 30.00 US$461,672
2025-03-10 2025-03-07 PlS Planned sale
Tupper Colleen

EVP & Chief Financial Officer

Officer
1,504 -0.8%
30.00
US$45,121 		1,504 -0.8% 30.00 US$45,121
2025-03-10 2025-03-07 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
2,348 -1.6%
30.00
US$70,446 		2,348 -1.6% 30.00 US$70,446
2025-03-07 2025-03-07 PrS Proposed sale
1.9
Dreyer Scott

Officer

Officer
2,348
30.00
US$70,446 		2,348 30.00 US$70,446
2025-03-07 2025-03-07 PrS Proposed sale
Tupper Colleen

Officer

Officer
1,504
30.00
US$45,121 		1,504 30.00 US$45,121
2025-03-13 2025-03-06 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
15,387 -10.8%
30.00
US$461,672 		15,387 -10.8% 30.00 US$461,672
2025-03-10 2025-03-06 PlS Planned sale
Tupper Colleen

EVP & Chief Financial Officer

Officer
1,949 -1.1%
30.00
US$58,470 		1,949 -1.1% 30.00 US$58,470
2025-03-10 2025-03-06 PlS Planned sale
1.9
Dreyer Scott

EVP & Chief Commercial Officer

Officer
3,295 -2.2%
30.00
US$98,854 		3,295 -2.2% 30.00 US$98,854
2025-03-06 2025-03-06 PrS Proposed sale
Tupper Colleen

Officer

Officer
1,949
30.00
US$58,470 		1,949 30.00 US$58,470
2025-03-06 2025-03-06 PrS Proposed sale
1.9
Dreyer Scott

Officer

Officer
3,295
30.00
US$98,854 		3,295 30.00 US$98,854
2025-03-06 2025-03-06 PrS Proposed sale
2.2
Kuhlmann Shirley R.

Officer

Officer
26,067
28.50
US$742,946 		26,067 28.50 US$742,946
2025-03-06 2025-03-06 S Sale
2.2
Kuhlmann Shirley R.

EVP and General Counsel

Officer
26,067 -19.4%
28.50
US$742,946 		26,067 -19.4% 28.50 US$742,946
2025-03-06 2025-03-05 S Sale
2.2
Kuhlmann Shirley R.

EVP and General Counsel

Officer
20,000 -13.0%
28.03
US$560,528 		20,000 -13.0% 28.03 US$560,528
2025-03-05 2025-03-05 PrS Proposed sale
2.2
Kuhlmann Shirley R.

Officer

Officer
20,000
28.03
US$560,528 		20,000 28.03 US$560,528
2025-03-06 2025-03-04 S Sale
2.2
Kuhlmann Shirley R.

EVP and General Counsel

Officer
40,000 -20.6%
28.08
US$1,123,160 		40,000 -20.6% 28.08 US$1,123,160
Explore more

More insider trading research around Collegium Pharmaceutical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America